BioMarin Pharmaceutical

BMRN · NASDAQ

$56.44+$1.77 (+3.24%)TodayMarket closed ·
Prev close $54.67

Who owns BMRN

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 51.3% of BMRN’s shares.

  • BlackRock Institutional Trust Company, N.A.9.0%
  • Dodge & Cox7.7%
  • PRIMECAP Management Company7.3%
  • Vanguard Capital Management, LLC4.5%
  • Next 6 largest institutions22.8%
  • All other shareholders48.7%
Top institutional holders of BMRN
HolderShares% of shares
BlackRock Institutional Trust Company, N.A.17.46M9.04%
Dodge & Cox14.84M7.68%
PRIMECAP Management Company14.19M7.34%
Vanguard Capital Management, LLC8.74M4.52%
Vanguard Portfolio Management, LLC8.65M4.47%
Norges Bank Investment Management (NBIM)8.21M4.25%
State Street Investment Management (US)7.80M4.04%
Viking Global Investors LP7.62M3.94%
Vestal Point Capital, LP6.03M3.12%
AQR Capital Management, LLC5.70M2.95%

Largest mutual fund holders

Top mutual fund holders of BMRN
HolderShares% of shares
Dodge & Cox Stock Fund9.77M5.05%
Statens Pensjonsfond Utland8.21M4.25%
iShares Core S&P Mid-Cap ETF6.77M3.50%
Vanguard Total Stock Market Index Fund6.16M3.19%
Vanguard Capital Opportunity Fund5.17M2.67%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $1.34M (2 trades) of BMRN on the open market, with no buys.

Latest BMRN insider transactions
InsiderTypeSharesValue
Friberg Gregory RTax withholding4.09K$245.16K
Plenge Robert MAward6.14K—
Davis George EricSale17.56K$1.16M
Countouriotis AthenaAward7.49K—
Walbert Timothy PAward7.49K—
Ho MaykinAward7.49K—
HOMBACH ROBERT J.Award7.49K—
Enyedy Mark JAward7.49K—
Dere Willard HAward7.49K—
CLARK IAN TAward7.49K—

Short interest

Settled Sep 30, 2026

Shares short
11.52M
Days to cover
5.51
% of shares outstanding
5.96%
Average daily volume
2.09M
Change since last report
+14.4%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.